Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect
Abstract
Dear Editor,
While common adverse events associated with sodium-glucose cotransporter-2 inhibitors—such as genitourinary infections and volume depletion—are well-characterized, rare immune-mediated cutaneous manifestations are increasingly recognized in post-marketing surveillance...
References
- Mederle AL, Dumitrescu P, Borza C, Kundnani NR. Cutaneous adverse drug reactions associated with SGLT2 inhibitors. J Clin Med 2024;14:188. DOI: https://doi.org/10.3390/jcm14010188
- Kowalska J, Wrześniok D. Skin-related adverse reactions induced by oral antidiabetic drugs-a review of literature and case reports. Pharmaceuticals 2024;17:847. DOI: https://doi.org/10.3390/ph17070847
- Andino Navarrete R, Puerto Troncoso C, Saldías Fuentes C. Drug-induced vasculitis: clinical, histopathologic findings, and prognostic outcomes. A cross-sectional study in the inpatient setting. J Am Acad Dermatol 2019;81:AB48. DOI: https://doi.org/10.1016/j.jaad.2019.06.207
- Kluger N, Francès C. Cutaneous vasculitis and their differential diagnoses. Clin Exp Rheumatol 2009;27:S124-38.
- Alpsoy E. Cutaneous vasculitis; An algorithmic approach to diagnosis. Front Med 2022;9:1012554. DOI: https://doi.org/10.3389/fmed.2022.1012554
- Goeser MR, Laniosz V, Wetter DA. A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis. Am J Clin Dermatol 2014;15:299-306. DOI: https://doi.org/10.1007/s40257-014-0076-6
- Micheletti RG. Treatment of cutaneous vasculitis. Front Med 2022;9:1059612. DOI: https://doi.org/10.3389/fmed.2022.1059612
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. DOI: https://doi.org/10.1038/clpt.1981.154
- Sunderkötter C, Golle L, Pillebout E, et al. Pathophysiology and clinical manifestations of immune complex vasculitides. Front Med 2023;10:1103065. DOI: https://doi.org/10.3389/fmed.2023.1103065
- Bhattacharyya S, Ghosh A. Dapagliflozin-induced cutaneous vasculitis, a hitherto unreported adverse effect. Indian J Dermatol 2024;69:355-7. DOI: https://doi.org/10.4103/ijd.ijd_211_24
- Kocabaş M, Yarar Z, Cordan I, et al. A case report of dapagliflozin-induced nodular vasculitis. Turk J Endocrinol Metab. 2021;25:129-132. DOI: https://doi.org/10.25179/tjem.2020-80188
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.